Suppr超能文献

在朝觐者中脑膜炎球菌和肺炎球菌的带菌情况:一项随机对照试验的结果。

Meningococcal and pneumococcal carriage in Hajj pilgrims: findings of a randomized controlled trial.

机构信息

Department of Family and Community Medicine, Faculty of Medicine in Rabigh, King Abdulaziz University, Jeddah 22252, Saudi Arabia.

National Centre for Immunisation Research and Surveillance (NCIRS), The Children's Hospital at Westmead, NSW 2145, Australia.

出版信息

J Travel Med. 2020 Jul 14;27(4). doi: 10.1093/jtm/taaa032.

Abstract

BACKGROUND

Intense congestion during the Hajj pilgrimage amplifies the risk of meningococcal carriage and disease, and there have been many meningococcal outbreaks reported amongst pilgrims. Thus, a strict vaccination policy is enforced by the host country and either polysaccharide or conjugate quadrivalent meningococcal vaccines are mandatory. However, unlike conjugate vaccines, the polysaccharide vaccine is not thought to reduce pharyngeal carriage of meningococci.

METHODS

A single-blinded, randomized, controlled trial amongst pilgrims from Saudi Arabia and Australia during the Hajj seasons of 2016-2017 was conducted to compare MenACWY-Conjugate vaccine with MenACWY-Polysaccharide vaccine, to determine if the conjugate vaccine is more effective in reducing asymptomatic carriage of meningococci, and whether the effect may be long-standing. Oropharyngeal swabs were obtained pre-, immediately post- and 6-11 months following completion of Hajj and tested for the presence of meningococci.

RESULTS

Amongst 2000 individuals approached, only 1146 participants aged 18-91 (mean 37.6) years agreed to participate and were randomized to receive either the polysaccharide (n = 561) or the conjugate (n = 561) vaccine, 60.8% were male, and 93.5% were from Saudi Arabia. Amongst oropharyngeal swabs obtained before Hajj, only two (0.2%) tested positive for Neisseria meningitidis. Similarly, meningococci were identified in only one sample at each of the post-Hajj and late follow-up visits. None of the carriage isolates were amongst the serogroups covered by the vaccines. A post hoc analysis of the third swabs revealed that 22.4% of all participants (50/223) were positive for Streptococcus pneumoniae nucleic acid.

CONCLUSION

The low overall carriage rate of meningococci found amongst Hajj pilgrims in 2016 and 2017 demonstrates a successful vaccination policy, but neither supports nor refutes the superiority of meningococcal conjugate ACWY vaccine over the polysaccharide vaccine against carriage. Although an association could not be established in this study, molecular epidemiology would help to establish the role of Hajj in facilitating transmission of pneumococci and inform vaccination policy.

摘要

背景

朝觐期间的拥挤加剧了脑膜炎奈瑟菌的传播和发病风险,且有许多朝觐者中爆发脑膜炎的报道。因此,主办国实行严格的疫苗接种政策,要求接种多糖或结合型四价脑膜炎球菌疫苗。然而,与结合疫苗不同的是,多糖疫苗被认为不能降低脑膜炎奈瑟菌的咽部携带率。

方法

2016-2017 年朝觐期间,对来自沙特阿拉伯和澳大利亚的朝觐者进行了一项单盲、随机、对照试验,以比较 MenACWY-结合疫苗和 MenACWY-多糖疫苗,确定结合疫苗是否更有效地降低无症状脑膜炎奈瑟菌的携带率,以及这种效果是否具有持久性。在朝觐前后 6-11 个月采集口咽拭子,检测脑膜炎奈瑟菌的存在情况。

结果

在 2000 名被接触的人中,只有 1146 名年龄在 18-91 岁(平均 37.6 岁)的参与者同意参加并被随机分配接受多糖(n=561)或结合(n=561)疫苗,60.8%为男性,93.5%来自沙特阿拉伯。在朝觐前采集的口咽拭子中,仅有 2 例(0.2%)脑膜炎奈瑟菌检测呈阳性。同样,在朝觐后和随访期间的每个时间点,也仅在一个样本中发现脑膜炎奈瑟菌。携带的分离株均不属于疫苗涵盖的血清群。对第三次拭子的事后分析显示,22.4%的所有参与者(50/223)肺炎链球菌核酸检测呈阳性。

结论

2016 年和 2017 年朝觐期间,脑膜炎奈瑟菌的总携带率较低,表明疫苗接种政策取得了成功,但既不能支持也不能反驳脑膜炎球菌结合 ACWY 疫苗对携带的效果优于多糖疫苗。尽管本研究未建立相关性,但分子流行病学将有助于确定朝觐在促进肺炎链球菌传播中的作用,并为疫苗接种政策提供依据。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验